Uamco Keystone's Stake in Qurient Slightly Decreases to 19.81% as Special Relation Sells Shares and Pledges Collateral; Management Influence Maintained
Uamco Keystone Structural Innovation Corporate Financial Stability Private Investment reported its stake in Qurient decreased by 2,000 shares or 0.15 percentage points to 7,787,060 shares or 19.81% compared to the previous report.
The decrease was due to open market sales of 2,000 shares by special relation Jang Jun-il, while another special relation Jo Yong-jun entered into a new collateral loan agreement pledging 90,000 shares for 800 million KRW at 8.0% interest with Sangsangin Securities.
The filer maintains a shareholder agreement with the largest shareholder Dong-A Pharmaceutical to influence management, with call and put options. Dong-A Pharmaceutical's consolidated total assets are 336.35 billion KRW, and Qurient's total assets are 26.0 billion KRW.
Uamco Keystone's managed assets are 90.89 billion KRW and equity is 90.78 billion KRW, with major shareholders United Asset Management and Keystone Private Equity each holding 6.97%.
[AI Summary]This report shows a minor share change due to small open market sales and a collateral loan, with negligible short-term impact on Qurient's stock price. The purpose of management influence is maintained through the shareholder agreement, and potential future exercise of put options could be a medium-term variable.